ArriVent BioPharma, Inc.

AVBP

ArriVent BioPharma, Inc.

AVBP

Insider Sentiment (TTM):

Last Purchase:2024-01-30Last Sale:2025-12-10Shares Purchased (TTM):0Shares Sold (TTM):555,555

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:41,883,937Shares Outstanding:45,067,658Institutional Ownership Pct.:92.94%

Earnings Market Reaction:

Filing Date:2026-05-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	62	46	113	113	50	74	283	299	317
Short Term Investments	264	267	188	123	126	-	-	-	-
Prepaid Expense And Other Assets Current	22	20	21	14	10	8	10	10	10
Assets Current	349	333	321	250	186	227	292	309	327
Long Term Investments	-	-	5	19	29	-	-	-	-
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0
Deferred Costs	0	-	-	-	-	-	-	-	-
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0
Assets	349	333	327	270	215	275	293	309	328
Liabilities And Stockhold…
Liabilities
Liabilities Current
Accounts Payable Current	9	6	6	4	4	4	5	4	4
Accrued Liabilities Current	16	20	16	15	8	13	10	8	6
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0
Liabilities Current	25	26	22	20	13	17	15	12	10
Operating Lease Liability Noncurrent	0	-	-	-	-	0	0	0	0
Liabilities	25	26	22	20	13	17	15	12	10
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	772	712	674	584	505	496	495	494	493
Retained Earnings Accumulated Deficit	-448	-405	-369	-334	-303	-238	-218	-197	-175
Accumulated Other Comprehensive Income Loss Net Of…	-0	0	0	-0	-0	-	-	-	-
Stockholders Equity	324	307	305	250	203	258	277	297	318
Liabilities And Stockholders Equity	349	333	327	270	215	275	293	309	328
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	45	42	41	37	34	34	34	34	33
Shares Outstanding	45	42	41	37	34	34	34	34	33

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	4.58%	-	-	-	-	-	-	-	-	-	-	-
2025	17.66%	3.90%	-6.65%	16.10%	14.09%	7.71%	32.74%	11.83%	20.91%	-15.13%	20.48%	5.86%
2024	11.81%	6.85%	28.92%	16.95%	13.82%	28.52%	4.20%	-1.99%	1.64%	-13.98%	-5.49%	-7.40%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Liquidity Ratios
Current Ratio	13.95	12.83	14.90	12.74	14.34	13.14	19.28	25.50	32.82
Quick Ratio	13.06	12.06	13.93	12.00	13.59	12.67	18.66	24.69	31.81
Working Capital	323.71M	306.95M	299.66M	230.51M	172.83M	209.71M	277.24M	296.41M	317.50M
Leverage & Debt
Debt to Equity	0.08	0.08	0.07	0.08	0.06	0.07	0.05	0.04	0.03
Debt Ratio	0.07	0.08	0.07	0.07	0.06	0.06	0.05	0.04	0.03
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Per Share Metrics
Diluted EPS TTM	-3.22	-4.32	-3.61	-3.91	-3.76	-2.56	-	-	-
Free Cash Flow Per Share TTM	-2.98	-4.18	-3.49	-3.62	-3.53	-2.23	-	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Growth Metrics
Net Income Growth (1Y)	13.95%	106.62%	-	-	-	-	-	-	-
EPS Growth (1Y)	-14.29%	69.06%	-	-	-	-	-	-	-
Valuation Metrics
P/E TTM	-7.16	-4.65	-5.11	-5.56	-4.92	-10.42	-	-	-
P/B	3.21	2.52	2.54	3.05	3.09	3.25	2.84	2.09	1.41
Market Cap	1.04B	773.87M	773.29M	762.08M	626.79M	838.34M	789.17M	621.47M	447.33M
Enterprise Value	978.03M	728.34M	660.68M	649.42M	577.06M	764.23M	506.53M	323.05M	130.22M
Calculated Values
Free Cash Flow TTM	-134.47M	-160.59M	-146.08M	-126.63M	-119.59M	-70.21M	-	-	-
Net Debt	-61.68M	-45.53M	-112.62M	-112.67M	-49.73M	-74.12M	-282.64M	-298.42M	-317.11M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-10Sale

Owner: Hhlr, Advisors, Ltd., Hil…

Title: -

Shares: 555,555

Price/Share: $23.37

Value: $12,983,320.35

Shares Owned: 3,929,117

Relationship: TenPercentOwner

Ownership: Indirect

2024-01-30Purchase

Owner: Hhlr, Advisors, Ltd., Hil…

Title: -

Shares: 555,555

Price/Share: $18.00

Value: $9,999,990.00

Shares Owned: 4,484,672

Relationship: TenPercentOwner

Ownership: Indirect

2024-01-30Purchase

Owner: Orbimed, Asia Gp Iv, L.P.…

Title: -

Shares: 444,444

Price/Share: $18.00

Value: $7,999,992.00

Shares Owned: 1,513,664

Relationship: Director,TenPercentOwner

Ownership: Indirect

2024-01-30Purchase

Owner: Gordon, Carl L

Title: -

Shares: 444,444

Price/Share: $18.00

Value: $7,999,992.00

Shares Owned: 1,513,664

Relationship: Director,TenPercentOwner

Ownership: Indirect

2024-01-30Purchase

Owner: Healy, James

Title: -

Shares: 444,444

Price/Share: $18.00

Value: $7,999,992.00

Shares Owned: 1,696,752

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-10	Hhlr, Advisors, Ltd., Hil…	TenPercentOwner	-	Indirect	Sale	555,555	23.37	$12,983,320.35	3,929,117	4
2024-01-30	Hhlr, Advisors, Ltd., Hil…	TenPercentOwner	-	Indirect	Purchase	555,555	18.00	$9,999,990.00	4,484,672	4
2024-01-30	Orbimed, Asia Gp Iv, L.P.…	Director,TenPercentOwner	-	Indirect	Purchase	444,444	18.00	$7,999,992.00	1,513,664	4
2024-01-30	Gordon, Carl L	Director,TenPercentOwner	-	Indirect	Purchase	444,444	18.00	$7,999,992.00	1,513,664	4
2024-01-30	Healy, James	Director	-	Indirect	Purchase	444,444	18.00	$7,999,992.00	1,696,752	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

2026-03-31

92.94%

Inst. Shares: 41,883,937

Shares Outstanding: 45,067,658

2025-12-31

103.93%

Inst. Shares: 39,973,271

Shares Outstanding: 38,462,600

2025-09-30

91.88%

Inst. Shares: 38,508,876

Shares Outstanding: 41,912,905

2025-06-30

95.34%

Inst. Shares: 33,375,167

Shares Outstanding: 35,006,114

2025-03-31

73.60%

Inst. Shares: 24,949,141

Shares Outstanding: 33,898,870

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	41,883,937	45,067,658	92.94%
2025-12-31	39,973,271	38,462,600	103.93%
2025-09-30	38,508,876	41,912,905	91.88%
2025-06-30	33,375,167	35,006,114	95.34%
2025-03-31	24,949,141	33,898,870	73.60%
2024-12-31	28,380,774	31,469,328	90.19%
2024-09-30	25,838,576	33,581,810	76.94%
2024-06-30	21,645,638	33,502,347	64.61%
2024-03-31	21,835,509	25,046,531	87.18%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.